Analysis of the Latin American Electronic Medical Record Market

  • March 2013
  • -
  • Frost & Sullivan
  • -
  • 115 pages

Current and Proposed Regulations will Boost the Market in Argentina, Colombia, and Mexico

This study analyzes the Latin American electronic medical record (EMR) market. For the purpose of this study, Latin America includes Argentina, Colombia, and Mexico only. The analysis is with regard to revenue, installed base, market share, and the competitive scenario. The base year for the study is 2012, and the end of the study period is 2017. The market is segmented by the size and type of healthcare institution as well as the type of EMR system needed. Enterprise EMR systems are used for tertiary healthcare institutes; middle EMR systems are implemented in secondary healthcare institutes, and mini EMR systems are used in primary healthcare institutions, also called ambulatory.

This study analyzes the Latin American electronic medical record (EMR) market. For the purpose of this study, Latin America includes Argentina, Colombia, and Mexico. The analysis is with regard to revenue, installed base, market share, and the competitive scenario.
In 2012, Mexico presented the highest adoption rate in the region with X implemented EMR systems— percent of the total healthcare institutions. In Colombia, the average adoption rate isXpercent, which represents X institutions with EMR systems installed. Finally, in Argentina, the total installed base is X with an adoption rate of X percent of total healthcare institutions.
The most representative and mature market for this solution is Colombia, representing Xpercent of the 2012 total market revenue, with 488 EMRs implemented. Argentina represents theXpercent of the 2012 total market revenue, with X implemented EMRs. Mexico, highly influenced by 2012 presidential elections, represents X percent of the total market revenue with 26 EMR units shipped.
In 2012, the total market presented a revenue of $X million and will reach $Xmillion by 2017, with a compound annual growth rate (CAGR) from 2012 to 2017 of X percent.

Key Questions This Study Will Answer

Is there any regulation that encourages the adoption of EMR systems? Are the governments investing in EMR for public healthcare institutions?
What is the size of the EMR market in Latin America? Is the market growing, how long will it continue to grow, and at what rate?
Which are the key business segments in the market? What is the contribution from each segment? What will be the impact of external trends on each business segment?
Who are the key participants in the EMR markets, and what kind of market dynamics exist?
What are the key challenges faced by participants in this market? What are the key market drivers and restraints? How is the market impacted by emerging trends in the external environment?
How will the structure of the market change with time? Is there any scope for innovation in business models?

Table Of Contents

Analysis of the Latin American Electronic Medical Record Market
Table Of Contents

1. Executive Summary

2. Market Overview

3. Total EMR Market

• External Challenges: Drivers and Restraints
• Forecast and Trends
• Demand Analysis
• Competitive Analysis

4. Argentina Breakdown

5. Colombia Breakdown

6. Mexican Breakdown

7. The Last Word

8. Appendix


View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • February 2015
  • by Global Data

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, ...

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • January 2015
  • by Global Data

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. ...

European Markets for Soft Tissue Reinforcement and Regeneration

European Markets for Soft Tissue Reinforcement and Regeneration

  • $ 10 995
  • Industry report
  • April 2015
  • by iData Research, Inc.

The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.